STAT+: Eli Lilly’s GLP-1 pill Foundayo helped alleviate sleep apnea in studies
Stat News • 11/9/2026
Summary
Eli Lilly’s GLP-1 pill Foundayo helped alleviate sleep apnea in two late-stage studies. However, it does not appear as effective as Lilly’s injectable drug Zepbound.
Advertisement
Lindy Score Breakdown (V4.2)
3h
Age
1
Sources
from cluster
1
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier99% (0.5^1/48)
Hero EligibleYes
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition
Stat News • Today
STAT+: Despite Novo drug’s failure, cardiologists say they will still pursue anti-inflammatories
Stat News • 2 days ago
STAT+: Failure of Novartis Lp(a) drug raises questions about cardiovascular strategy
Stat News • 2 days ago
STAT+: MAHA leader Calley Means castigates White House officials as bending to industry
Stat News • 2 days ago
STAT+: Gene therapy’s long-debated cancer risk materializes
Stat News • Today
STAT+: Democrats begin asking: How far can we go on health care?
Stat News • Today
STAT+: Why the latest heart drug failures should make us all more skeptical of AI hype
Stat News • 1 day ago
STAT+: Pharmalittle: We’re reading about a Novartis heart drug, BIO fighting a Trump program, and more
Stat News • Today
STAT+: Heart association meeting’s readout is trending ‘neutral’
Stat News • Today
STAT+: A new rule to prevent the spread of bioweapons
Stat News • Today